Radius Health, Inc.
RDUS
RDUS was delisted on the 12th of August, 2022.
18 hedge funds and large institutions have $192M invested in Radius Health, Inc. in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
+$53.8M |
| 2 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$25.3M |
| 3 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
+$16.8M |
| 4 |
WT
Wellcome Trust
London,
United Kingdom
|
+$15.9M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$12M |
Top Sellers
RDUS Hedge Fund Activity: Q2 2014 in Review
18 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Radius Health, Inc. (RDUS) for Q2 2014, worth a combined $192M.
Buyers outnumbered sellers: 18 funds opened new RDUS positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was MPM Asset Management, opening a new position worth an estimated $53.8M.
- 18 institutional investors held Radius Health, Inc. (RDUS) as of Q2 2014, up from 0 in Q1 2014.
- Funds reported $192M of Radius Health, Inc. stock for Q2 2014.
- 18 funds opened new Radius Health, Inc. positions in Q2 2014 and 0 closed out, a net change of +18 holders.
- The largest Radius Health, Inc. buyer in Q2 2014 was MPM Asset Management, an estimated $53.8M added.
Based on aggregated 13F filings for Q2 2014.